$AMN

BofA Adjusts Price Target on AMN Healthcare Services to $28 From $26

Bank of America raised its price target for AMN Healthcare Services from $26 to $28. The stock has seen a 5-day change of 34.92 USD, a 1st Jan change of +2.25%, and a 1-year change of +3.53%.

Original reporting
Published Sep 16, 2026, 12:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 11:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AMN
Bullish
medium confidence
Mentioned
$AMN
Relevance
6/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$AMNBullishLow
01

Why it matters

Analyst target changes can influence short‑term trading but lack the depth of earnings or M&A news.

02

Market read

A modest analyst upgrade that may prompt short‑term buying interest in AMN.

03

What to watch

Potential headwinds in labor market and regulatory changes for staffing firms.

Relevance 6/10Novelty 5/10Timing: pre-market today

Background

BofA's target adjustment is part of its composite rating methodology, reflecting valuation and EPS revisions.

Company-level read

Ticker impact

$AMNBullishMedium confidence
Context

BofA raised its price target for AMN Healthcare Services to $28 from $26, indicating a fresh analyst upgrade.

Expected impact

Expect modest price appreciation in the near term as investors adjust expectations.

Evidence & confidence

Analyst target changes often move the stock, but the magnitude is modest and no new fundamental data accompanies it.

Market effects

May slightly lift the healthcare staffing sector as peers are re‑rated.

Limited to U.S. markets; no broader regional effect.

Minimal global impact.

Counterpoint

The target raise could be premature without new earnings or contract news.

Key entities

  • BofA Securities

    Provides the price target upgrade for AMN.

  • AMN Healthcare Services

    Subject of the price target change.

Related articles

$AMNMed

AMN Healthcare (AMN) Swings To Profit While Two Segments Keep Sliding

AMN Healthcare (AMN) reported Q2 revenue of $673.2M, up 2% YoY, with net income of $21.2M. Travel nurse and allied staffing revenue grew 10% and 8% YoY, respectively. However, Physician and Leadership Solutions revenue fell 6% and Technology and Workforce Solutions revenue dropped 15% YoY. The company expects these declines to continue in Q3.

$AMNMed

AMN Healthcare Adds AI Interpreting as Prices Squeezed

AMN Healthcare reported Q2 2026 language services revenue of $69.6m, down 8% YoY due to pricing pressure. Overall revenue rose 2% to $673.2m, with net income at $21.2m. The company acquired Jaide Health for AI interpreting services and expects Q3 revenue of $640m-$655m.

$AMNMedAI 9/10

AMN Healthcare (AMN) Q2 2026 Earnings Call Transcript

AMN Healthcare reported Q2 2026 revenue of $673 million, up 2% year over year and 6% above the top end of guidance, with adjusted EPS of $0.77. Adjusted EBITDA was $73 million (10.9% margin) after $27 million in nonrecurring billing true-ups. Q3 revenue guidance is $640 million to $655 million. AMN also authorized share repurchases and acquired Jaide Health and ESSENTIAL.

$AMNMedAI 8/10

5 Revealing Analyst Questions From AMN Healthcare Services’s Q2 Earnings Call

AMN Healthcare Services reported Q2 revenue of $673.2 million, above analysts’ $628.2 million estimate, and adjusted EPS of $0.77 versus $0.19. Management attributed results to strong Nurse and Allied Solutions demand, including travel nurse and allied volumes, plus higher labor disruption revenue and improved search and international execution. Q3 revenue guidance midpoint was $647.5 million.

$AMNHighAI 9/10

AMN HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS

AMN Healthcare Services (NYSE: AMN) reported Q2 2026 revenue of $673 million, up 2% year over year, and adjusted EBITDA of $73 million. GAAP net income was $21 million, or $0.53/share, and adjusted EPS was $0.77. The company said results exceeded guidance, citing travel nurse and allied growth, 27% search revenue growth, and acquisitions expanding AI and leadership offerings. Q3 revenue is expected 1-3% higher.